AU2022355276A1 - Peptide - Google Patents

Peptide Download PDF

Info

Publication number
AU2022355276A1
AU2022355276A1 AU2022355276A AU2022355276A AU2022355276A1 AU 2022355276 A1 AU2022355276 A1 AU 2022355276A1 AU 2022355276 A AU2022355276 A AU 2022355276A AU 2022355276 A AU2022355276 A AU 2022355276A AU 2022355276 A1 AU2022355276 A1 AU 2022355276A1
Authority
AU
Australia
Prior art keywords
amino acid
peptide
tgf
peptide according
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022355276A
Other languages
English (en)
Inventor
Masahiko KINEBUCHI
Yoshinori Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peptidream Inc
Original Assignee
Peptidream Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptidream Inc filed Critical Peptidream Inc
Publication of AU2022355276A1 publication Critical patent/AU2022355276A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2022355276A 2021-09-30 2022-09-30 Peptide Pending AU2022355276A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021161353 2021-09-30
JP2021-161353 2021-09-30
PCT/JP2022/036850 WO2023054712A1 (ja) 2021-09-30 2022-09-30 ペプチド

Publications (1)

Publication Number Publication Date
AU2022355276A1 true AU2022355276A1 (en) 2024-05-16

Family

ID=85780814

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022355276A Pending AU2022355276A1 (en) 2021-09-30 2022-09-30 Peptide

Country Status (10)

Country Link
US (1) US20250034212A1 (https=)
EP (1) EP4410816A4 (https=)
JP (1) JPWO2023054712A1 (https=)
KR (1) KR20240082377A (https=)
CN (1) CN118103387A (https=)
AU (1) AU2022355276A1 (https=)
CA (1) CA3234324A1 (https=)
IL (1) IL311773A (https=)
TW (1) TW202334179A (https=)
WO (1) WO2023054712A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025070720A1 (ja) * 2023-09-29 2025-04-03 ペプチドリーム株式会社 ペプチド
TW202535907A (zh) * 2023-11-10 2025-09-16 日商肽夢想股份有限公司 胜肽、胜肽複合體、醫藥組成物、細胞培養用組成物、以及用於醫療用、診斷用或是研究用之組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240912A (en) * 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US5525491A (en) 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
WO2001066140A1 (en) 2000-03-09 2001-09-13 Genzyme Corporation Use of tgf-beta antagonists to treat or to prevent loss of renal function
BR0116024A (pt) 2000-12-07 2005-12-13 Lilly Co Eli Proteìna de fusão heteróloga e uso da mesma
EP1534737A4 (en) * 2002-04-29 2007-10-31 Univ Saint Louis PEPTIDANTAGONISTS OF MEMBERS OF THE TGF BETA FAMILY AND THEIR THERAPEUTIC APPLICATION
US8188260B2 (en) 2005-12-06 2012-05-29 The University Of Tokyo Versatile acylation catalytic RNAs and uses thereof
MY165160A (en) 2010-09-01 2018-02-28 Genzyme Corp TREATMENT OF MYOCARDIAL INFARCTION USING TGF-ß ANTAGONISTS
HRP20201384T1 (hr) 2014-01-01 2020-11-27 Medivation Technologies Llc Spojevi i postupci njihove upotrebe
US10882894B2 (en) * 2015-08-11 2021-01-05 Anie Philip Peptidic TGF-beta antagonists
JP6952747B2 (ja) 2018-09-18 2021-10-20 ファイザー・インク がん処置のためのＴＧＦβ阻害剤およびＣＤＫ阻害剤の組合せ

Also Published As

Publication number Publication date
EP4410816A1 (en) 2024-08-07
CN118103387A (zh) 2024-05-28
EP4410816A4 (en) 2025-11-19
US20250034212A1 (en) 2025-01-30
WO2023054712A1 (ja) 2023-04-06
JPWO2023054712A1 (https=) 2023-04-06
IL311773A (en) 2024-05-01
KR20240082377A (ko) 2024-06-10
CA3234324A1 (en) 2023-04-06
TW202334179A (zh) 2023-09-01

Similar Documents

Publication Publication Date Title
AU2024200512B2 (en) Stabilized peptide-mediated targeted protein degradation
RU2631931C2 (ru) Модуляция специфичности структурированных белков
WO2015030014A1 (ja) 大環状ペプチド、その製造方法、及び大環状ペプチドライブラリを用いるスクリーニング方法
CN115151556A (zh) 人转铁蛋白受体结合肽
EP4410816A1 (en) Peptide
AU2022242421A2 (en) Peptide and peptide-containing composition
JPWO2016063969A1 (ja) ヘマグルチニン結合ペプチド
WO2023022234A1 (ja) ヒトトランスフェリンレセプター結合ペプチド
JP7580120B2 (ja) ヘマグルチニン結合ペプチド
US20250282820A1 (en) Peptide complex having trkb binding activity
JP7854211B2 (ja) ヘマグルチニン結合ペプチド
CA3130694C (en) Hemagglutinin-binding peptide
TW202434613A (zh) 人類運鐵蛋白受體結合肽
AU2024347940A1 (en) Peptide
HK40105341A (zh) 人转铁蛋白受体结合肽
CN121925425A (zh) 肽
WO2025047927A1 (ja) Ｖｅｇｆｒ－２アゴニスト活性を有するペプチド複合体
JP2024523280A (ja) Ｇｈｒ結合ペプチドおよびそれを含む組成物
US20260116920A1 (en) Human transferrin receptor binding peptide
HK40105891A (zh) 人转铁蛋白受体结合抗体-肽缀合物
IL317677A (en) Peptide and peptide containing active factor
HK40057758B (zh) 血球凝集素结合肽
HK40057758A (en) Hemagglutinin-binding peptide
Wen Development and Application of Cell Penetrating Beta-Hairpin and Alpha-Helical Peptides